Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2010-09-27T12:39:51Z
dc.date.available 2010-09-27T03:00:00Z
dc.date.issued 2010 es
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/8014
dc.description.abstract This study introduced a novel phase separation technique for the microencapsulation of metoprolol tartrate as a model. Non-solvent addition coacervation technique was employed for the loading of drug into ethylcellulose, a hydrophobic plastic polymer. Dichloromethane (DCM) and paraffin oil were employed as solvent and non-solvent, respectively. Microparticle batches abbreviated as M1, M2 and M3 were formulated by embedding 1 g of drug into 1 g, 2 g and 3 g of polymer, respectively followed by direct compression into tabletted microparticulate batches named a T1, T2 and T3, respectively. The drug and polymer remained intact in encapsulated form as confirmed by FTIR, XRD and DSC. However, a slight change in drug nature from crystalline to amorphous behavior and an endothermic peak for metoprolol tartrate at 130 ºC was observed in drug and microparticle thermograms. Slightly aggregated spherical free flowing microparticles in a size range of 64 μm-103 μm were obtained. The entrapment efficiency ranged from 77% to 89%. The straight line obtained from a plot between square root of time (Hrs) versus drug release (%) and regression co-efficient (R2) confirmed that best fit model to all dissolution profiles was Higuchi's model. The modes of drug release from microparticles and tabletted microparticles were Quasi-Fickian diffusion and anomalous diffusion, respectively. T3 was selected as an optimum formulation as its dissolution profile resembled (f2 = 76.25) Mepressor® (Novartis Pharma-Pakistan). The accelerated stability study, regarding dissolution behavior and drug contents, at 40ºC/75% RH proved T3 stable in 40 ºC/75% RH for six months. Non-solvent addition coacervation technique involving comparatively safe solvents such as dichloromethane and paraffin oil as solvent and non-solvent, respectively is a good techniques for the encapsulation of Biopharmaceutics Classification System class I drugs such as metoprolol tartrate. es
dc.format.extent 984-990 es
dc.language en es
dc.subject dissolution; ethylcellulose; kinetic models; metoprolol tartrate; non-solvent addition coacervation es
dc.subject Farmacología es
dc.subject Disolución es
dc.subject Polímeros es
dc.subject Química orgánica es
dc.title Metoprolol tartrate-ethylcellulose tabletted microparticles: formulation and in vitro evaluation es
dc.type Articulo es
sedici.identifier.uri http://www.latamjpharm.org/resumenes/29/6/LAJOP_29_6_1_19.pdf es
sedici.creator.person Rasool, Fatima es
sedici.creator.person Ahmad, Mahmood es
sedici.creator.person Murtaza, Ghulam es
sedici.creator.person Khan, Haji M. S. es
sedici.creator.person Khan, Shujaat A. es
sedici.subject.materias Farmacia es
sedici.description.fulltext false es
mods.originInfo.place Colegio de Farmacéuticos de la Provincia de Buenos Aires es
sedici.subtype Articulo es
sedici.description.peerReview peer-review es
sedici2003.identifier ARG-FARM-ART-0000001501 es
sedici.relation.journalTitle Latin American Journal of Pharmacy es
sedici.relation.journalVolumeAndIssue vol. 29, no. 6 es


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)